RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)		1 Months Ended
	Jan. 12, 2018	May 28, 2021	Dec. 28, 2020	Nov. 17, 2017	May 17, 2017	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021	Mar. 31, 2021	Jan. 31, 2021	Jan. 08, 2021	Dec. 12, 2020	Sep. 30, 2020	Dec. 12, 2019
Proceeds From Director		$ 150,000
Proceeds From Chairman		$ 50,000
Debt Interest Rate								5.00%
Company Paid Cmh									$ 50,000		$ 50,000		$ 40,000
Obligation Of The Initial Payment									300,000		300,000		300,000
Cash Payment In Intial Payment														$ 50,000
Common Stock Issued						6,520,690	6,338,872
Preferred Stock Series A [Member]
Reimbursement Of Management Fees				$ 45,000
Management Reimbursement agreement CMH [Member]
Reimbursement Of Management Fees				$ 45,000
StemSpine Patent Purchase [Member]
Company Paid Cmh										$ 50,000	50,000		40,000
Obligation Of The Initial Payment										$ 300,000	$ 300,000		$ 300,000
Common Stock Issued										89,286	133	6,667	84,656
Company owed CMH						$ 0			$ 5,082
Long-term Purchase Commitment, Amount					$ 100,000
Cash Payment In Intial Payment												$ 50,000
Remaining portion of obligation paid in cash										$ 300,000
Debt Settlement Agreement Timothy Warbington [Member]
Series A Preferred Stock Issued	3,000,000
Cancellation Of Debt	$ 150,000
Preferred Stock Surrender And Exchange Description	Mr. Warbington surrendered the Series A Preferred Stock to the Company in December 2021 immediately prior to the closing of the Company’s public offering in exchange for $150,000 plus 8% interest on such amount from January 2018 until the date of surrender
Jadi Cell License Agreement [Member]
License Fee			$ 250,000
Agreement Description			Company entered into a patent license agreement with Jadi Cell, LLC, a company owned and controlled by Dr. Amit Patel, a former director of the Company
Common Stock Issued			181,818